Found: 30
Select item for more details and to access through your institution.
Defining IgM multiple myeloma.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 8, p. 717, doi. 10.1002/ajh.22061
- By:
- Publication type:
- Article
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project.
- Published in:
- Cytometry. Part B, 2018, v. 94, n. 1, p. 121, doi. 10.1002/cyto.b.21595
- By:
- Publication type:
- Article
Measuring disease levels in myeloma using flow cytometry in combination with other laboratory techniques: Lessons from the past 20 years at the Leeds Haematological Malignancy Diagnostic Service.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 54, doi. 10.1002/cyto.b.21271
- By:
- Publication type:
- Article
Assessment of minimal residual disease in myeloma and the need for a consensus approach.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 21, doi. 10.1002/cyto.b.21272
- By:
- Publication type:
- Article
Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 31, doi. 10.1002/cyto.b.21228
- By:
- Publication type:
- Article
Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 26, doi. 10.1002/cyto.b.21249
- By:
- Publication type:
- Article
Assessment of Bone Marrow Response in Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 53
- By:
- Publication type:
- Article
Immunoglobulin Heavy Chain Sequence Analysis in Waldenström's Macroglobulinemia and Immunoglobulin M Monoclonal Gammopathy of Undetermined Significance.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 1, p. 70
- By:
- Publication type:
- Article
Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination.
- Published in:
- Genes, Chromosomes & Cancer, 2004, v. 39, n. 2, p. 151, doi. 10.1002/gcc.10304
- By:
- Publication type:
- Article
Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
- Published in:
- Oncogene, 2003, v. 22, n. 7, p. 1103, doi. 10.1038/sj.onc.1206335
- By:
- Publication type:
- Article
Immunoglobulin M Concentration in Waldenström Macroglobulinemia: Correlation With Bone Marrow B Cells and Plasma Cells.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 211, doi. 10.1016/j.clml.2013.02.018
- By:
- Publication type:
- Article
Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 11, p. 1812, doi. 10.1002/art.40937
- By:
- Publication type:
- Article
Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 2, p. 171, doi. 10.1111/bjh.12102
- By:
- Publication type:
- Article
Translocation t(14;16) in IgM multiple myeloma.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 3, p. 402, doi. 10.1111/j.1365-2141.2011.08687.x
- By:
- Publication type:
- Article
A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 5, p. 570, doi. 10.1111/j.1365-2141.2010.08317.x
- By:
- Publication type:
- Article
Extramedullary plasmacytoma are characterized by a 'myeloma-like' immunophenotype and genotype and occult bone marrow involvement.
- Published in:
- British Journal of Haematology, 2010, v. 151, n. 5, p. 525, doi. 10.1111/j.1365-2141.2010.08386.x
- By:
- Publication type:
- Article
IgM myeloma: a rare entity characterized by a CD20<sup>−</sup>CD56<sup>−</sup>CD117<sup>−</sup> immunophenotype and the t(11;14).
- Published in:
- British Journal of Haematology, 2008, v. 140, n. 5, p. 547, doi. 10.1111/j.1365-2141.2007.06969.x
- By:
- Publication type:
- Article
Overview of monoclonal B-cell lymphocytosis.
- Published in:
- British Journal of Haematology, 2007, v. 139, n. 5, p. 701, doi. 10.1111/j.1365-2141.2007.06865.x
- By:
- Publication type:
- Article
The biological and clinical relationship between CD5<sup>+</sup>23<sup>+</sup> monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2007, v. 139, n. 5, p. 724, doi. 10.1111/j.1365-2141.2007.06863.x
- By:
- Publication type:
- Article
Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience.
- Published in:
- British Journal of Haematology, 2007, v. 139, n. 5, p. 845, doi. 10.1111/j.1365-2141.2007.06864.x
- By:
- Publication type:
- Article
Cyclooxygenase-2 (COX-2) in multiple myeloma: prognostic factor or therapeutic target?
- Published in:
- British Journal of Haematology, 2007, v. 136, n. 1, p. 163, doi. 10.1111/j.1365-2141.2006.06376.x
- By:
- Publication type:
- Article
MBL and MoBL – Response to Ziegler-Heitbrock.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Diagnostic criteria for monoclonal B-cell lymphocytosis.
- Published in:
- British Journal of Haematology, 2005, v. 130, n. 3, p. 325, doi. 10.1111/j.1365-2141.2005.05550.x
- By:
- Publication type:
- Article
Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 4, p. 573, doi. 10.1111/bjh.14342
- By:
- Publication type:
- Article
Ibrutinib induces chromatin reorganisation of chronic lymphocytic leukaemia cells.
- Published in:
- Oncogenesis, 2019, v. 8, n. 5, p. N.PAG, doi. 10.1038/s41389-019-0142-2
- By:
- Publication type:
- Article
Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
GA101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL (GALACTIC) trial: study protocol for a phase II/III randomised controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Occult B-cell lymphoproliferative disorders.
- Published in:
- Histopathology, 2011, v. 58, n. 1, p. 81, doi. 10.1111/j.1365-2559.2010.03702.x
- By:
- Publication type:
- Article
A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.803175
- By:
- Publication type:
- Article